4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0000930413-17-002350
CIK 0001328143operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 8:48 PM ET
Size
14.3 KB
Accession
0000930413-17-002350
Insider Transaction Report
Form 4
GREAT POINT PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock
2017-06-20$17.35/sh−20,000$346,934→ 2,231,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-19$17.05/sh−350,000$5,967,675→ 2,251,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-21$17.44/sh−10,000$174,365→ 2,216,351 total(indirect: Investment Mgr.)
JAY JEFFREY R
10% Owner
Transactions
- Sale
Common Stock
2017-06-19$17.05/sh−350,000$5,967,675→ 2,251,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-20$17.35/sh−20,000$346,934→ 2,231,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-21$17.44/sh−10,000$174,365→ 2,216,351 total(indirect: Investment Mgr.)
KROIN DAVID
10% Owner
Transactions
- Sale
Common Stock
2017-06-21$17.44/sh−10,000$174,365→ 2,216,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-19$17.05/sh−350,000$5,967,675→ 2,251,351 total(indirect: Investment Mgr.) - Sale
Common Stock
2017-06-20$17.35/sh−20,000$346,934→ 2,231,351 total(indirect: Investment Mgr.)
Footnotes (7)
- [F1]Consists of 94,851 shares owned by Biomedical Value Fund, L.P. ("BVF"), 145,713 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 103,098 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 6,338 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
- [F2]Consists of 610,121 shares owned by Biomedical Value Fund, L.P. ("BVF"), 937,287 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 663,176 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 40,767 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
- [F3]Great Point Partners, LLC ("Great Point") is the investment manager of each of BVF, BOVF, GEF-SMA and GEF-PS, and by virtue of such status may be deemed to be the beneficial owner of the shares owned by each of them. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as senior managing member of Great Point, and Mr. David Kroin ("Mr. Kroin"), as special managing member of Great Point, has voting and investment power with respect to such shares, and therefore may be deemed to be the beneficial owner of such shares. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests.
- [F4]Consists of 5,420 shares owned by Biomedical Value Fund, L.P. ("BVF"), 8,327 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 5,891 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 362 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
- [F5]Consists of 604,701 shares owned by Biomedical Value Fund, L.P. ("BVF"), 928,960 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 657,285 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 40,405 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
- [F6]Consists of 4,065 shares owned by Biomedical Value Fund, L.P. ("BVF"), 6,245 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 4,418 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 272 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
- [F7]Consists of 600,636 shares owned by Biomedical Value Fund, L.P. ("BVF"), 922,715 shares owned by Biomedical Offshore Value Fund, Ltd. ("BOVF"), 652,867 shares owned by GEF-SMA, L.P. ("GEF-SMA"), and 40,133 shares owned by Class D Series of GEF-PS, LP ("GEF-PS").
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 8:48 PM ET
- Size
- 14.3 KB